Jeff Yass’s Aclaris Therapeutics ACRS Stock Holding History
Bought
Maintained
Sold
Other funds holding ACRS
BCM
Jeff Yass's ACRS Position: Q3 2026 in Review
Jeff Yass reduced its Aclaris Therapeutics (ACRS) stake by 0.18% in Q3 2026, selling an estimated $4.18K and leaving 411,816 shares worth $2.17M. The position accounts for ﹤0.01% of the portfolio, ranked #6088.
Jeff Yass first reported a position in ACRS in Q1 2017 and has held it in 30 quarters since. The position peaked at $11.3M in Q1 2021. 167 funds tracked by Wall St. Rank hold ACRS as of Q3 2026.
- Jeff Yass held 411,816 shares of Aclaris Therapeutics worth $2.17M as of Q3 2026.
- Jeff Yass sold 733 Aclaris Therapeutics shares in Q3 2026, an estimated $4.18K.
- Aclaris Therapeutics made up ﹤0.01% of Jeff Yass's portfolio in Q3 2026, its #6088 holding.
- Jeff Yass first reported a position in Aclaris Therapeutics in Q1 2017 and has held it in 30 quarters since.
- Jeff Yass's Aclaris Therapeutics position peaked at $11.3M in Q1 2021.
- 167 funds tracked by Wall St. Rank held Aclaris Therapeutics as of Q3 2026.
Based on Susquehanna International Group's 13F filing for Q3 2026, filed 16 Nov 2026.